Literature DB >> 2789508

Atrial fibrillation and mortality in an elderly population.

F R Lake1, K J Cullen, N H de Klerk, M G McCall, D L Rosman.   

Abstract

Prospective data from Busselton, Western Australia, collected during triennial surveys from 1966-81 with follow-up of subjects to 1983, showed that atrial fibrillation (AF) was frequent in elderly people and associated with increased mortality. Of 1770 people aged over 60 years, 40 were in atrial fibrillation when first seen and a further 47 developed it during follow-up. Atrial fibrillation was positively associated with angina, history of a myocardial infarction and left bundle branch block. Relative mortality in those with atrial fibrillation compared with those without it, was 1.92 for all causes, 1.82 for death from cardiovascular causes (excluding stroke) and 3.78 for deaths from stroke, after adjustment by proportional hazards regression for confounding effects of age, sex, history of a myocardial infarction, an abnormal electrocardiogram, angina, cholesterol level systolic blood pressure and Quetelet's Index (weight/height2). The excess relative mortality declined with increasing age for both women and men. This raised relative mortality remained constant with time from the first detection of AF for all causes and cardiovascular causes but appeared to increase with time from detection for stroke death. The risk of death from stroke was greatest in the younger women. The observed risk of death from stroke in patients with AF suggests that anticoagulant use should be considered in selected patients.

Entities:  

Mesh:

Year:  1989        PMID: 2789508     DOI: 10.1111/j.1445-5994.1989.tb00271.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  35 in total

Review 1.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 2.  Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk.

Authors:  T E Cuddy
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 3.  Non-rheumatic atrial fibrillation: warfarin or aspirin for all?

Authors:  J Nolan; P Bloomfield
Journal:  Br Heart J       Date:  1992-12

Review 4.  Anticoagulants in older patients. A safety perspective.

Authors:  R J Beyth; C S Landefeld
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

5.  Management of Atrial Fibrillation: Identifying and treating the causes.

Authors:  S W Rabkin
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

Review 6.  Is anticoagulation therapy underused in elderly patients with atrial fibrillation?

Authors:  F M Turazza; M G Franzosi
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

7.  A practical approach to the management of patients with atrial fibrillation.

Authors:  Christopher J McLeod; Bernard J Gersh
Journal:  Heart Asia       Date:  2010-09-06

Review 8.  Atrial fibrillation and heart failure in the elderly.

Authors:  Pedram Kazemian; Gavin Oudit; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 9.  Development of the Maze procedure and the contribution of Japanese surgeons.

Authors:  Shinya Takahashi; Taijiro Sueda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-11-16

Review 10.  Prevention of embolic complications in nonvalvular atrial fibrillation in the elderly.

Authors:  F R Lake; P L Thompson
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.